Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis
- PMID: 7129642
- DOI: 10.1007/BF01666910
Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis
Abstract
Thirty patients with antimicrobial agent-associated pseudomembranous colitis (PMC) were studied for the presence of Clostridium difficile and its cytotoxin in feces. Either colonoscopy or barium enema radiography was required in three patients for the diagnosis of PMC because of nondiagnostic findings at sigmoidoscopy. Both the organism and cytotoxin were detected in 27 of the 30 patients; Staphylococcus aureus was excluded as the cause of PMC in two of the remaining patients. Eighteen of 19 patients with C. difficile-induced PMC who were treated with oral vancomycin had a salutary response; seven patients, however, had a relapse of colitis following the discontinuation of vancomycin. In general, relapses of colitis responded to retreatment with vancomycin. The implication of C. difficile as a cause of diarrhea is best achieved by the demonstration of colonic mucosal plaques or of a pseudomembrane. The value of fecal culture for C. difficile and cytotoxin assay is limited by the existence of asymptomatic carriers.
Similar articles
-
Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.J Clin Microbiol. 1982 Jun;15(6):1049-53. doi: 10.1128/jcm.15.6.1049-1053.1982. J Clin Microbiol. 1982. PMID: 7107838 Free PMC article.
-
Antimicrobial agent-associated colitis and diarrhea: historical background and clinical aspects.Rev Infect Dis. 1984 Mar-Apr;6 Suppl 1:S208-13. doi: 10.1093/clinids/6.supplement_1.s208. Rev Infect Dis. 1984. PMID: 6372031 Review.
-
Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy.Gut. 1983 Mar;24(3):206-12. doi: 10.1136/gut.24.3.206. Gut. 1983. PMID: 6826104 Free PMC article.
-
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.Gastroenterology. 1981 Jul;81(1):5-9. Gastroenterology. 1981. PMID: 7239125
-
Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.Ann Biol Clin (Paris). 1989;47(2):67-70. Ann Biol Clin (Paris). 1989. PMID: 2660635 Review.
Cited by
-
SMT19969 as a treatment for Clostridium difficile infection: an assessment of antimicrobial activity using conventional susceptibility testing and an in vitro gut model.J Antimicrob Chemother. 2015 Jan;70(1):182-9. doi: 10.1093/jac/dku324. Epub 2014 Sep 3. J Antimicrob Chemother. 2015. PMID: 25190720 Free PMC article.
-
Laboratory diagnosis of Clostridium difficile-associated diarrhoea.Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):476-84. doi: 10.1007/BF01962596. Eur J Clin Microbiol Infect Dis. 1988. PMID: 3141153 Review.
-
Clostridium difficile toxins: mechanism of action and role in disease.Clin Microbiol Rev. 2005 Apr;18(2):247-63. doi: 10.1128/CMR.18.2.247-263.2005. Clin Microbiol Rev. 2005. PMID: 15831824 Free PMC article. Review.
-
Host response to Clostridium difficile infection: Diagnostics and detection.J Glob Antimicrob Resist. 2016 Dec;7:93-101. doi: 10.1016/j.jgar.2016.08.002. Epub 2016 Sep 20. J Glob Antimicrob Resist. 2016. PMID: 27693863 Free PMC article. Review.
-
Analysis of proline reduction in the nosocomial pathogen Clostridium difficile.J Bacteriol. 2006 Dec;188(24):8487-95. doi: 10.1128/JB.01370-06. Epub 2006 Oct 13. J Bacteriol. 2006. PMID: 17041035 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical